Volume 13, Number 6—June 2007
Letter
Multidrug-Resistant Acinetobacter baumannii
Vladimir Krcmery*
and Erich Kalavsky†
and Erich Kalavsky†Table
Risk factors and outcome for 27 neutropenic cancer patients with bacteremia due to multidrug-resistant (MDR) or drug-susceptible Acinetobacter baumannii infection
| Characteristic | All patients, no. (%) (N = 27) | Patients with drug-susceptible A. baumannii, no. (%)* (n = 12, 44%) | Patients with MDR A. baumannii, no. (%)* (n = 15, 56%) |
|---|---|---|---|
| Risk for bacteremia | |||
| Central venous catheter | 19 (70.4) | 9 (75.0) | 10 (66.7) |
| Acute leukemia | 11 (40.7) | 6 (50.0) | 5 (33.3) |
| Previous prophylaxis with quinolones | 14 (51.9) | 8 (66.7) | 6 (40.0) |
| Previous therapeutic treatment with cephalosporins | 15 (55.6) | 8 (66.7) | 7 (46.7) |
| Previous therapeutic treatment with carbapenems | 8 (29.6) | 4 (33.3) | 4 (26.7) |
| Outcome | |||
| Septic shock | 4 (14.8) | 2 (16.7) | 2 (13.3) |
| Death | 2 (7.4) | 1 (8.3) | 1 (6.7) |
*Insignificant difference between patients with drug-susceptible infection and those with MDR infection (p<0.05 by univariate analysis).
